<div id="readability-page-1"><p>Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 16,283,031 shares,  a growth of 22.5% from the December 15th total of 13,292,515 shares. Approximately 14.3% of the company's shares are short sold. Based on an average daily trading volume, of 5,914,386 shares, the days-to-cover ratio is presently 2.8 days. Based on an average daily trading volume, of 5,914,386 shares, the days-to-cover ratio is presently 2.8 days. Approximately 14.3% of the company's shares are short sold.</p><div><p><span></span><span>Get <strong>Amprius Technologies</strong> alerts:</span></p></div><h2>Wall Street Analyst Weigh In</h2><ul><li>Amprius Technologies Signals Electrifying Growth in 2026</li></ul><p>A number of analysts have recently issued reports on AMPX shares. Weiss Ratings  reiterated a &#34;sell (e+)&#34; rating on shares of Amprius Technologies in a report on Wednesday, October 8th. Northland Securities  set a $20.00 target price on shares of Amprius Technologies in a research report on Tuesday, October 7th. Cantor Fitzgerald raised their price target on Amprius Technologies from $12.00 to $16.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, November 7th. Roth Capital  set a $14.00 target price on shares of Amprius Technologies and gave the stock a &#34;buy&#34; rating in a research note on Wednesday, October 22nd. Finally, Oppenheimer  restated an &#34;outperform&#34; rating and set a $17.00 price objective on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Seven research analysts have rated the stock with a Buy rating and one  has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $14.57.</p><p><b>Get Our Latest Research Report on Amprius Technologies</b></p><h2>Amprius Technologies Trading Up 8.4%</h2><ul><li>5 Stocks to Stuff Your Portfolio This November</li></ul><p>Amprius Technologies stock traded up $0.85 during midday trading on Monday, reaching $11.00. The company's stock had a trading volume of 10,450,358 shares, compared to its average volume of 5,669,739. The stock has a market cap of $1.44 billion, a PE ratio of -42.31 and a beta of 3.04. Amprius Technologies has a 52 week low of $1.70 and a 52 week high of $16.03. The business has a 50-day moving average price of $10.22 and a 200-day moving average price of $9.66. </p><p>Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. The firm had revenue of $21.43 million during the quarter, compared to analysts' expectations of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%.  As a group, research analysts predict that  Amprius Technologies will post -0.45 EPS for the current fiscal year. </p><h2>Insider Buying and Selling at Amprius Technologies</h2><ul><li>October’s Top 5 Stocks Poised for Big Breakouts</li></ul><p>In other Amprius Technologies news, Director Kang Sun sold 506,267 shares of Amprius Technologies stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $10.10, for a total transaction of $5,113,296.70. Following the transaction, the director directly owned 1,403,651 shares in the company, valued at approximately $14,176,875.10. The trade was a 26.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CTO Constantin Ionel Stefan sold 198,255 shares of the business's stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $10.51, for a total value of $2,083,660.05. Following the completion of the transaction, the chief technology officer directly owned 748,696 shares of the company's stock, valued at approximately $7,868,794.96. The trade was a 20.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,798,201 shares of company stock worth $18,741,241 in the last ninety days. 12.90% of the stock is currently owned by company insiders. </p><h2>Institutional Trading of Amprius Technologies</h2><p>A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Quarry LP bought a new position in  Amprius Technologies in the third quarter valued at about $42,000.  Jones Financial Companies Lllp increased its stake in shares of  Amprius Technologies by 353.2% in the third quarter. Jones Financial Companies Lllp now owns 4,532 shares of the company's stock valued at $50,000 after buying an additional 3,532 shares during the period.  Parallel Advisors LLC acquired a new position in shares of  Amprius Technologies in the third quarter valued at approximately $54,000.  Geneos Wealth Management Inc. bought a new position in  Amprius Technologies in the 3rd quarter valued at approximately $74,000.  Finally, Ameritas Investment Partners Inc. boosted its position in  Amprius Technologies by 2,043.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company's stock worth $40,000 after buying an additional 9,072 shares during the period. Institutional investors own  5.04% of the company's stock. </p><h2>About Amprius Technologies</h2> (Get Free Report)<p>Amprius Technologies, Inc <span>NYSE: AMPX<span></span></span> is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.  </p><p>At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Amprius Technologies</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>Do not delete, read immediately</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Executive Order 14330: Trump’s Biggest Yet</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Amprius Technologies Right Now?</h2><p>Before you consider Amprius Technologies, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.</p><p>While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AMPX

<p>Amprius Technologies, Inc. (NYSE:AMPX) experienced a significant increase in short interest, rising by 22.5% in December, totaling 16,283,031 shares. Currently, 14.3% of the company's stock is sold short, with a days-to-cover ratio of 2.8 days based on an average daily trading volume of 5,914,386 shares. Analysts have mixed ratings on the stock, with a consensus target price of $14.57. The stock recently traded at $11.00, up 8.4%, with a market cap of $1.44 billion. Insiders have sold a total of 1,798,201 shares in the last ninety days.</p>

Short Interest in Amprius Technologies, Inc. (NYSE:AMPX) Increases By 22.5%